UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in KURA — Kura Oncology, Inc.
CIK 861177
NEW YORK, NY
Position in KURA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,009,361
-$101,212 QoQ
Shares Held
124,153
+16.2% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45.41090428745178.ToString("F0")%
Shared 0.ToString("F0")%
None 54.58909571254823.ToString("F0")%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. KURA ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in KURA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,009,361 | 124,153 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,110,573 | 106,889 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $980,277 | 110,766 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,094,683 | 189,720 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,004,068 | 152,132 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,147,261 | 131,718 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,396,931 | 122,668 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,575,888 | 125,104 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,848,582 | 86,666 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,177,086 | 81,856 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $746,525 | 81,856 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $422,871 | 39,969 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $488,818 | 39,969 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $569,853 | 45,919 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $627,252 | 45,919 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,240,664 | 340,462 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,636,535 | 350,531 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,204,500 | 371,750 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,176,114 | 383,135 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,187,019 | 392,663 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,480,320 | 299,976 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,469,258 | 259,316 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,185,767 | 38,700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $623,311 | 38,240 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $154,383 | 15,516 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||